Triple

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Phrase: Public Law 97-248 | Statement: [Tax Equity and Fiscal Responsibility Act of 1982, publicLawNumber, Public Law 97-248]

Target entity: Public Law 97-248
Context triple: [Tax Equity and Fiscal Responsibility Act of 1982, publicLawNumber, Public Law 97-248]

• A. Public Law 96-487
  Public Law 96-487 is the U.S. federal statute, known as the Alaska National Interest Lands Conservation Act of 1980, that greatly expanded national parks, wildlife refuges, and wilderness areas across Alaska.
• B. Public Law 96-448
  Public Law 96-448 is the formal designation of the Staggers Rail Act of 1980, a landmark U.S. federal law that substantially deregulated the railroad industry to improve its financial stability and efficiency.
• C. Public Law 99-474
  Public Law 99-474 is the 1986 U.S. federal statute that enacted the Computer Fraud and Abuse Act, establishing key criminal penalties for unauthorized access to computer systems.
• D. Public Law 93-148
  Public Law 93-148 is the formal statutory designation of the U.S. War Powers Resolution, a 1973 federal law intended to limit the president’s authority to commit U.S. forces to armed conflict without congressional approval.
• E. Public Law 97-414
  Public Law 97-414 is the U.S. federal statute commonly known as the Orphan Drug Act of 1983, which incentivizes the development of treatments for rare diseases through benefits such as market exclusivity and tax credits.
• F. None of above. chosen
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"

Entity: Public Law 97-248
Triple: [Tax Equity and Fiscal Responsibility Act of 1982, publicLawNumber, Public Law 97-248]

Public Law 97-248 is the formal designation of the Tax Equity and Fiscal Responsibility Act of 1982, a major U.S. federal law that increased taxes and implemented budgetary reforms to reduce the national deficit.

Target entity: Public Law 97-248
Target entity description: Public Law 97-248 is the formal designation of the Tax Equity and Fiscal Responsibility Act of 1982, a major U.S. federal law that increased taxes and implemented budgetary reforms to reduce the national deficit.

• A. Public Law 96-487
  Public Law 96-487 is the U.S. federal statute, known as the Alaska National Interest Lands Conservation Act of 1980, that greatly expanded national parks, wildlife refuges, and wilderness areas across Alaska.
• B. Public Law 96-448
  Public Law 96-448 is the formal designation of the Staggers Rail Act of 1980, a landmark U.S. federal law that substantially deregulated the railroad industry to improve its financial stability and efficiency.
• C. Public Law 99-474
  Public Law 99-474 is the 1986 U.S. federal statute that enacted the Computer Fraud and Abuse Act, establishing key criminal penalties for unauthorized access to computer systems.
• D. Public Law 93-148
  Public Law 93-148 is the formal statutory designation of the U.S. War Powers Resolution, a 1973 federal law intended to limit the president’s authority to commit U.S. forces to armed conflict without congressional approval.
• E. Public Law 97-414
  Public Law 97-414 is the U.S. federal statute commonly known as the Orphan Drug Act of 1983, which incentivizes the development of treatments for rare diseases through benefits such as market exclusivity and tax credits.
• F. None of above. chosen